Fund Holdings — MPM BioImpact LLC

Total Portfolio Value:
$873.95M
Total Bought:
$373.21M
Total Sold:
$315.68M
Net Transaction:
+$57.53M
Notable People:
Ansbert K Gadicke
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Cullinan Therapeutics, Inc.(CGEM)7,648,2687,648,2680$45.35M$79.16M9.06%+$33.81M
Madrigal Pharmaceuticals, Inc.(MDGL)100,41596,780-3,635$46.06M$56.36M6.45%+$10.30M
Liquidia Corporation(LQDA)200,0001,400,869+1,200,869$4.55M$48.32M5.53%+$43.77M
Trevi Therapeutics, Inc.(TRVI)3,406,9553,287,087-119,868$31.17M$41.15M4.71%+$9.98M
Edgewise Therapeutics, Inc.(EWTX)1,720,7411,655,256-65,485$27.91M$41.08M4.70%+$13.16M
Revolution Medicines, Inc.(RVMD)315,722505,672+189,950$14.74M$40.28M4.61%+$25.53M
Agios Pharmaceuticals, Inc.(AGIO)01,303,373+1,303,373$0$35.48M4.06%+$35.48M
uniQure N.V.(QURE)01,381,628+1,381,628$0$33.06M3.78%+$33.06M
PTC Therapeutics, Inc.(PTCT)438,477430,013-8,464$26.91M$32.66M3.74%+$5.75M
Syndax Pharmaceuticals, Inc.(SNDX)1,375,6741,337,702-37,972$21.16M$28.11M3.22%+$6.94M
Dyne Therapeutics, Inc.(DYN)1,446,3611,405,388-40,973$18.30M$27.49M3.15%+$9.19M
Tarsus Pharmaceuticals, Inc.(TARS)341,496328,869-12,627$20.30M$26.93M3.08%+$6.63M
Stoke Therapeutics, Inc.(STOK)789,698770,289-19,409$18.56M$24.45M2.80%+$5.89M
Alumis Inc02,401,992+2,401,992$0$23.44M2.68%+$23.44M
UroGen Pharma Ltd.(URGN)135,000941,378+806,378$2.69M$22.05M2.52%+$19.35M
Xenon Pharmaceuticals Inc.(XENE)503,398485,620-17,778$20.21M$21.77M2.49%+$1.55M
Palvella Therapeutics, Inc.(PVLA)67,423205,745+138,322$4.23M$21.54M2.46%+$17.31M
Natera, Inc.(NTRA)98,92493,551-5,373$15.92M$21.43M2.45%+$5.51M
Corvus Pharmaceuticals, Inc.(CRVS)02,743,671+2,743,671$0$21.13M2.42%+$21.13M
DBV Technologies S.A.ADS(DBVT)1,054,504996,825-57,679$10.55M$19.11M2.19%+$8.56M
Relay Therapeutics, Inc.(RLAY)2,282,6802,232,451-50,229$11.92M$18.89M2.16%+$6.97M
Monte Rosa Therapeutics, Inc.(GLUE)01,173,376+1,173,376$0$18.40M2.11%+$18.40M
Bright Minds Biosciences Inc.(DRUG)0230,147+230,147$0$17.96M2.06%+$17.96M
Protagonist Therapeutics Inc0199,471+199,471$0$17.42M1.99%+$17.42M
enGene Holdings, Inc.
COM
530,2991,840,898+1,310,599$3.62M$16.62M1.90%+$13.00M
Context Therapeutics Inc.(CNTX)14,705,88210,679,391-4,026,491$14.25M$15.70M1.80%+$1.45M
Arcutis Biotherapeutics, Inc.(ARQT)0531,200+531,200$0$15.43M1.77%+$15.43M
Ventyx Biosciences Inc01,639,061+1,639,061$0$14.80M1.69%+$14.80M
ORIC Pharmaceuticals, Inc.(ORIC)1,729,3781,798,717+69,339$20.75M$14.71M1.68%-$6.04M
Belite Bio, IncADS(BLTE)087,760+87,760$0$14.04M1.61%+$14.04M
RAPT Therapeutics Inc0397,906+397,906$0$13.48M1.54%+$13.48M
Climb Bio, Inc.(CLYM)02,671,480+2,671,480$0$10.69M1.22%+$10.69M
ABIVAX Société AnonymeADS(ABVX)056,316+56,316$0$7.59M0.87%+$7.59M
Rocket Pharmaceuticals, Inc.(RCKT)3,903,3811,586,076-2,317,305$12.73M$5.57M0.64%-$7.16M
Maze Therapeutics, Inc.(MAZE)081,145+81,145$0$3.36M0.38%+$3.36M
Evommune, Inc.(EVMN)0113,022+113,022$0$1.93M0.22%+$1.93M
Sarepta Therapeutics, Inc.(SRPT)700,00070,000-630,000$13.49M$1.51M0.17%-$11.98M
Werewolf Therapeutics, Inc.(HOWL)2,408,8101,393,557-1,015,253$4.75M$883.5K0.10%-$3.86M
Akebia Therapeutics, Inc.(AKBA)2,889,1250-2,889,125$7.89M$0—-$7.89M
Alkermes plc(ALKS)549,2620-549,262$16.48M$0—-$16.48M
ARS Pharmaceuticals, Inc.(SPRY)1,303,3990-1,303,399$13.10M$0—-$13.10M
Assembly Biosciences Inc39,6650-39,665$1.02M$0—-$1.02M
Avidity Biosciences Inc760,0220-760,022$33.11M$0—-$33.11M
Cartesian Therapeutics, Inc.(RNAC)380,0000-380,000$3.88M$0—-$3.88M
Compass Therapeutics, Inc.(CMPX)5,075,9700-5,075,970$17.77M$0—-$17.77M
Design Therapeutics, Inc.(DSGN)555,1870-555,187$4.18M$0—-$4.18M
Janux Therapeutics, Inc.(JANX)614,2820-614,282$15.01M$0—-$15.01M
Rapport Therapeutics, Inc.(RAPP)71,8070-71,807$2.13M$0—-$2.13M
Repare Therapeutics, Inc.819,9240-819,924$1.44M$0—-$1.44M
Soleno Therapeutics Inc150,0000-150,000$10.14M$0—-$10.14M
Solid Biosciences Inc1,634,5690-1,634,569$10.09M$0—-$10.09M
Ultragenyx Pharmaceutical Inc.(RARE)395,7000-395,700$11.90M$0—-$11.90M
Vera Therapeutics, Inc.CL A(VERA)563,0750-563,075$16.36M$0—-$16.36M
Wave Life Sciences, Inc.(WVE)1,505,2620-1,505,262$11.02M$0—-$11.02M
Zai Lab LimitedADR(ZLAB)745,0600-745,060$25.25M$0—-$25.25M
Page 1 of 1
MPM BioImpact LLC — 13F Holdings — Q4 2025 | TickerTrail